It will be quite difficult to raise $4m via retail entitlement when investors can buy from the market below the SPP price.
After hearing all those positive updates from the management in the past few months, seeing a CR on such a low SP pushed investor confidence to an all time low. Many early investors (including HP or myself) may feel themselves mislead, which is quite obvious from the current SP.
The management should start providing fortnightly updates on their operations to increase transparency & gain back investor trust. Now that OBM has an on-site lab (similar to DEG), more frequent updates on exploration results would be much appreciated too.
- Forums
- ASX - By Stock
- [Video] Ora Banda Mining Set To Undertake 21M Placement
It will be quite difficult to raise $4m via retail entitlement...
-
- There are more pages in this discussion • 95 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
Add OBM (ASX) to my watchlist
|
|||||
Last
42.5¢ |
Change
0.035(8.97%) |
Mkt cap ! $789.4M |
Open | High | Low | Value | Volume |
40.5¢ | 43.8¢ | 40.5¢ | $4.676M | 11.16M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 25555 | 42.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
42.5¢ | 109998 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 25555 | 0.420 |
1 | 2412 | 0.415 |
1 | 10075 | 0.405 |
4 | 133188 | 0.400 |
2 | 31392 | 0.395 |
Price($) | Vol. | No. |
---|---|---|
0.430 | 39683 | 4 |
0.435 | 25000 | 1 |
0.440 | 73445 | 2 |
0.445 | 3500 | 1 |
0.450 | 87000 | 4 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
OBM (ASX) Chart |